Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer [Phase 3]
Phase 3 trial update examining anastrozole with or without fulvestrant as first-line therapy in postmenopausal women with metastatic breast …
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Flaxseed in Treating Postmenopausal Women With Hot Flashes Who Have a History of Breast Cancer or Other Cancer or Who Do Not Wish to Take Estrogen Therapy [Phase 3]
A completed Phase 3 trial studied flaxseed for managing hot flashes in postmenopausal women with a history of breast cancer or other cancers…
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells for Metastatic Breast Cancer Treated With Chemo [Phase 3]
Phase 3 SWOG trial evaluating using circulating tumor cell levels to guide chemotherapy decisions in metastatic breast cancer; results poste…
-
CLINICAL_TRIALS withdrawal · 2017-04-04Clinical Trial Update: The Use of an Acellular Dermal Matrix in a Two-Staged Breast Reconstruction [Phase 4]
Phase 4 clinical trial update reporting termination of a study evaluating acellular dermal matrix in two-staged breast reconstruction after …
-
CLINICAL_TRIALS research · 2017-04-04Clinical Trial Update: Multi-Indication, Retrospective Oncological Study to Validate the Accuracy in Predicting TTP by PrediCare in Patients Under SOC
A retrospective, multi-indication study sponsored by Optimata Ltd. to validate PrediCare's ability to predict Time To Progression in cancer …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Fluorescence-guided Resection in Breast Cancer [Phase 2]
The Phase 2 trial evaluating fluorescence-guided resection for breast cancer (NCT01110954) sponsored by photonamic GmbH & Co. KG has been te…
-
CLINICAL_TRIALS withdrawal · 2017-04-04Clinical Trial Update: Delayed Effects of Treatment in Cancer Survivors (DETECS)
The DETECS clinical trial (NCT02067637) investigating delayed treatment effects in cancer survivors has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Joint Pain and Medication Adherence in Postmenopausal Women Receiving Aromatase Inhibitors
This clinical trial update notes a completed study examining joint pain (arthralgia) and medication adherence in postmenopausal women treate…
-
CLINICAL_TRIALS research · 2017-04-04Clinical Trial Update: Impact of Radiotherapy on Patients Undergoing DIEP Flap Breast Reconstruction
This clinical trial update examines whether radiotherapy affects outcomes for patients undergoing DIEP flap breast reconstruction in breast …
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: An Observational Study Evaluating the Productivity and Health-Related Quality of Life of People With HER2 Positive Breast Cancer
A completed observational study sponsored by Hoffmann-La Roche evaluated productivity and health-related quality of life in people with HER2…
-
FDA approval · 2017-03-31FDA Approved: IBRANCE — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for IBRANCE (palbociclib) submitted by Pfizer, resulting in an update to the drug's labeling.
-
CLINICAL_TRIALS trial_result · 2017-03-31Clinical Trial Update: Preoperative Cisplatin and Bevacizumab in ER-, PR-, HER2 Negative Breast Cancer [Phase 2]
Phase 2 trial evaluating preoperative cisplatin and bevacizumab in ER-, PR-, HER2-negative breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-03-31Clinical Trial Update: Effect of Kinesiotaping for the Treatment of Hormone-induced Myalgia in Women Given Breast Cancer Survivors [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial examining whether Kinesiotaping can treat hormone-induced myalgia in women who are breast cancer surviv…
-
CLINICAL_TRIALS trial_result · 2017-03-31Clinical Trial Update: Upstaging of ALH/LCIS Found on Core Biopsy Based on Subsequent Excisional Biopsy
Clinical trial update indicating that atypical lobular hyperplasia and lobular carcinoma in situ detected on core biopsy may be upstaged aft…
-
CLINICAL_TRIALS trial_result · 2017-03-31Clinical Trial Update: Study of Neoadjuvant Chemotherapy With Nanoparticle Albumin Bound Paclitaxel, Doxorubicin and Cyclophosphamide (NAC) in Patients With Stages II-III Breast Cancer [Phase 1]
Phase 1 neoadjuvant chemotherapy trial evaluating nab-paclitaxel, doxorubicin, and cyclophosphamide in patients with stage II-III breast can…
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer [Phase 3]
A Phase 3 trial compared exemestane, letrozole, and anastrozole as adjuvant therapy in postmenopausal women undergoing surgery for Stage II …
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: Phase 2 Trial of Selinexor (KPT-330) for Metastatic Triple Negative Breast Cancer (TNBC) [Phase 2]
Phase 2 trial of selinexor (KPT-330) in metastatic triple-negative breast cancer has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: Eribulin With Trastuzumab as First-line Therapy for Locally Recurrent or Metastatic HER2 Positive Breast Cancer [Phase 2]
Phase 2 trial update of eribulin with trastuzumab as first-line therapy for locally recurrent or metastatic HER2-positive breast cancer has …
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk Status [NA]
This clinical trial on lymphedema prophylaxis for high-risk breast cancer survivors has completed and posted its results in March 2017.
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Trial Using Docetaxel Cytoxan in Breast Cancers With High Recurrence Scores [Phase 2]
Phase 2 trial of docetaxel plus cyclophosphamide for breast cancer with high recurrence scores was terminated; results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: ELDA: Elderly Breast Cancer - Docetaxel in Adjuvant Treatment [Phase 3]
This update reports the completion of a Phase 3 trial evaluating docetaxel as adjuvant therapy for elderly breast cancer patients.
-
FDA approval · 2017-03-27FDA Approved: HERCEPTIN — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for HERCEPTIN (trastuzumab) submitted by Genentech, Inc.
-
CLINICAL_TRIALS trial_result · 2017-03-27Clinical Trial Update: Docetaxel and Carboplatin With or Without Trastuzumab Before Surgery in Treating Women With Locally Advanced Breast Cancer [Phase 2]
Phase 2 trial evaluating docetaxel and carboplatin with or without trastuzumab before surgery in locally advanced breast cancer has complete…
-
CLINICAL_TRIALS trial_result · 2017-03-27Clinical Trial Update: Bone Health Management for Women Diagnosed With Breast Cancer [NA]
A completed clinical trial evaluating bone health management in women diagnosed with breast cancer.
-
CLINICAL_TRIALS trial_result · 2017-03-24Clinical Trial Update: Phase 2 Study of Gemzar, Taxol & Avastin Combination as 1st Line Treatment for Metastatic Breast Cancer [Phase 2]
Phase 2 trial of gemcitabine, paclitaxel, and bevacizumab as first-line therapy for metastatic breast cancer has completed and posted result…